CN Patent

CN103180801B — 触觉通信

Assigned to Nokia Technologies Oy · Expires 2016-08-03 · 10y expired

What this patent protects

根据本发明的一个示例性实施方式，一种装置包括：可附着到皮肤的材料，该材料能够检测磁场并且向皮肤传送可感知的刺激，其中可感知的刺激与磁场有关。

USPTO Abstract

根据本发明的一个示例性实施方式，一种装置包括：可附着到皮肤的材料，该材料能够检测磁场并且向皮肤传送可感知的刺激，其中可感知的刺激与磁场有关。

Drugs covered by this patent

Abilify (aripiprazole) · Generic (originally Otsuka/BMS)

Patent Metadata

Patent number: CN103180801B
Jurisdiction: CN
Classification: —
Expires: 2016-08-03
Drug substance claim: No
Drug product claim: No
Assignee: Nokia Technologies Oy
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.